Publications

Havey TC, Fowler RA, Pinto R, Elligsen M, Daneman N. Duration of Antibiotic Therapy for Critically Ill Patients with Bloodstream Infections: A Retrospective Cohort Study. Can J Infect Dis Med Microbiol. 2013;24(3):129-37. PMID:24421823

Burns KEA, Meade MO, Lessard MR, Hand L, Zhou Q, Keenan SP, Lellouche F. Wean Earlier and Automatically with New Technology (The WEAN Study): A Multicentre Pilot RCT. Am J Respir Crit Care Med. 2013 Jun 1;187(11):1203-11.

Cook D, McDonald E, Smith O, Zytaruk N, Heels-Ansdell D, Watpool I, McArdle T, Matte A, Clarke F, Vallance S, Finfer S, Galt P, Crozier T, Fowler R, Arabi Y, Woolfe C, Orford N, Hall R, Adhikari N, Ferland MC, Marshall JD, Meade M for the PROTECT Investigators, CCCTG and ANZICS-CTG. Coenrolment of Critically Ill Patients into Multiple Studies: Patterns, Predictors and Consequences. Crit Care 2013;17:R1-R8.

Daneman N, Sarwar S, Fowler RA, Cuthbertson BH. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis. 2013 Apr;13(4):328-41.

Lamontagne F, Martinez HQ, Adhikari N, Cook D, Koo K, Lauzier F, Turgeon A, Kho M,  Burns KEA, Chant C, Fowler R, Douglas I, Poulin Y, Choong K, Ferguson ND, Meade MO. Corticosteroid in the Intensive Care Unit: A Survey of Intensivists. Can J Anaesth. 2013 Apr 19.

Turgeon AF, Lauzier F, Burns KE, Meade MO, Scales DC, Zarychanski R, Moore L, Zygun DA, McIntyre LA, Kanji S, Hébert PC, Murat V, Pagliarello G, Fergusson DA; for the Canadian Critical Care Trials Group.   Determination of neurologic prognosis and clinical decision making in adult patients with severe traumatic brain injury: a survey of Canadian intensivists, neurosurgeons, and neurologists. Crit Care Med. 2013 Apr;41(4):1086-93. PMID: 23385104

Burns KEA, Zubrinich C, Tan W, Raptis S, Xiong W, Smith O, McDonald E, Marshall JC, Saginur R, Heslegrave R, Rubenfeld G, Cook DJ; for the Canadian Critical Care Trials Group.  Research Recruitment Practices of Critically Ill Patients: A Multicenter, Cross-Sectional Study (The Consent Study).    Am J Respir Crit Care Med. 2013 Jun 1;187(11):1212-8.  [Epub ahead of print].  PMID: 23525935

Smith OM, McDonald E, Zytaruk N, Foster D, Matte A, Clarke F, Meade L, O’Callaghan N, Vallance S, Galt P, Rajbhandari D, Rocha M, Mehta S, Ferguson ND, Hall R, Fowler R, Burns K, Qushmaq I, Ostermann M, Heels-Ansdell, Cook DJ for the PROTECT Research Coordinators, PROTECT Investigators, Canadian Critical Care Trials Group, and the Australian, New Zealand Intensive Care Society Clinical Trials Group. Rates and determinants of informed consent: A case study of an international thromboprophylaxis trial. J Crit Care 2013;28: 28-39. PMID: 23089679

Koo KK, Cook DJ, Lamontagne F, Campbell E, Hand L, Clarke F, Zytaruk N, McLeod A, Soucy I, Boutin M, Priestap F, Meade MO on behalf of the Canadian Critical Care Trials Group.  Inter-rater Reliability of Observed, Stated and Documented Acute Rehabilitation in Canadian Intensive Care Units.  Am J Respir Crit Care Med 2013  (in press)

Clarke F, Foster D, Laberge A, O'Callaghan N, Thompson P, Meade L, Julien L, Watpool I, Ashley BJ,  Marinoff N, Cook D, for the Co-operative Network of Critical Care Knowledge Translation for Thromboprophylaxis (CONECCKT-T) Investigators and the CCCTG REB and Contract Approval Times for a Multicenter Audit. Crit Care Med 2013 (in press).

Cook D, Arabi Y, Ferguson N, Heels-Ansdell D, Freitag A, McDonald E, Clarke F, Keenan S, Pagliarello G, Plaxton W, Herridge M, Karachi T, Vallance S, Cade J, Crozier T, Alves da Silva S, Costa Filho R, Brandao N, Watpool I, McArdle T, Hollinger G, Mandourah Y, Al-Hazmi M, Zytaruk N, Adhikari NK; PROTECT Research Coordinators; PROTECT Investigators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group. Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis. Intensive Care Med. 2013;39(12):2115-25. PMID:24022796

Bagshaw SM,Sood MM, Long J, Fowler RA, Adhikari NK; Canadian Critical Care Trials Group H1N1 Collaborative. Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: cohort study. BMC Nephrol. 2013;14:123. PMID:23763900

Muscedere J, Ofner M, Kumar A, Long J, Lamontagne F, Cook D, McGeer A, Chant C, Marshall J, Jouvet P, Fowler R; ICU-FLU Group; Canadian Critical Care Trials Group. The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection. Chest. 2013 Jul;144(1):39-47. PMID:23392627

Ferguson ND, Scales DC, Pinto R, Wilcox ME, Cook DJ, Guyatt GH, Schünemann HJ, Marshall JC, Herridge MS, Meade MO; Canadian Critical Care Trials Group. Integrating mortality and morbidity outcomes: using quality-adjusted life years in critical care trials. Am J Respir Crit Care Med. 2013;187(3):256-61. PMID:23204250

Muscedere J, Sinuff T, Heyland DK, Dodek PM, Keenan SP, Wood G, Jiang X, Day AG, Laporta D, Klompas M; Canadian Critical Care Trials Group. The clinical impact and preventability of ventilator-associated conditions in critically ill patients who are mechanically ventilated. Chest. 2013 Nov;144(5):1453-60. PMID: 24030318

Sinuff T, Muscedere J, Adhikari NK, Stelfox HT, Dodek P, Heyland DK, Rubenfeld GD, Cook DJ, Pinto R, Manoharan V, Currie J, Cahill N, Friedrich JO, Amaral A, Piquette D, Scales DC, Dhanani S, Garland A; KRITICAL Working Group, the Canadian Critical Care Trials Group, and the Canadian Critical Care Society. Knowledge translation interventions for critically ill patients: a systematic review. Crit Care Med. 2013;41(11):2627-4. PMID: 23939356

Williamson DR, Albert M, Heels-Ansdell D, Arnold DM, Lauzier F, Zarychanski R, Crowther M, Warkentin TE, Dodek P, Cade J, Lesur O, Lim W, Fowler R, Lamontagne F, Langevin S, Freitag A, Muscedere J, Friedrich JO, Geerts W, Burry L, Alhashemi J, Cook D; PROTECT collaborators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group. Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest. 2013 Oct;144(4):1207-15. PMID: 23788287

Warkentin TE, Sheppard JA, Heels-Ansdell D, Marshall JC, McIntyre L, Rocha MG, Mehta S, Davies AR, Bersten AD, Crozier TM, Ernest D, Vlahakis NE, Hall RI, Wood GG, Poirier G, Crowther MA, Cook DJ; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group. Heparin-induced thrombocytopenia in medical surgical critical illness. Chest. 2013 Sep;144(3):848-58. PMID: 23722881

Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG; Canadian Critical Care Trials Group. A randomized trial of glutamine and antioxidants in critically ill patients.N Engl J Med. 2013;368(16):1489-97. PMID: 23594003

Smith OM, Wald R, Adhikari NK, Pope K, Weir MA, Bagshaw SM; Canadian Critical Care Trials Group. Standard versus accelerated initiation of renal replacement therapy in acute kidney injury (STARRT-AKI): study protocol for a randomized controlled trial. Trials. 2013;14:320. PMID: 24093950

Ferguson ND, Cook DJ, Guyatt GH, Mehta S, Hand L, Austin P, Zhou Q, Matte A, Walter SD, Lamontagne F, Granton JT, Arabi YM, Arroliga AC, Stewart TE, Slutsky AS, Meade MO; OSCILLATE Trial Investigators; Canadian Critical Care Trials Group.High-frequency oscillation in early acute respiratory distress syndrome.N Engl J Med. 2013 Feb 28;368(9):795-805. PMID: 23339639

mplement Sci. 2013 Dec 4;8:140. doi: 10.1186/1748-5908-8-140. Development and psychometric properties of a questionnaire to assess barriers to feeding critically ill patients. Cahill NE, Day AG, Cook D, Heyland DK; Canadian Critical Care Trials Group.Development and psychometric properties of a questionnaire to assess barriers to feeding critically ill patients.Implement Sci. 2013 Dec 4;8:140. PMID: 24305039

Arnold DM, Lauzier F, Rabbat C, Zytaruk N, Barlow Cash B, Clarke F, Heels-Ansdell D, Guyatt G, Walter SD, Davies A, Cook DJ; PROTECT Investigators, on behalf of the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group.Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness.Thromb Res. 2013 Mar;131(3):204-9. PMID: 23317632

Lauzier F, Arnold DM, Rabbat C, Heels-Ansdell D, Zarychanski R, Dodek P, Ashley BJ, Albert M, Khwaja K, Ostermann M, Skrobik Y, Fowler R, McIntyre L, Nates JL, Karachi T, Lopes RD, Zytaruk N, Finfer S, Crowther M, Cook D. Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis. Intensive Care Med. 2013;39(12):2135-43. PMID: 23942857